Researchers at the Johns Hopkins Kimmel Cancer Center validated an artificial intelligence (AI)-powered blood test that accurately detected liver cancer in people from two geographically and ...
Hebrew University researchers say the discovery could pave the way for new cancer treatments and earlier detection of dozens ...
Every time a cell divides, it must accurately copy and distribute its DNA between two new cells. However, in some cases, chromosomes do not fully separate, leaving behind thin strands of DNA known as ...
A protein and signaling pathway may help overcome the developmental block that keeps some leukemia cells immature.
The company is betting heavily on its cancer pipeline, particularly intismeran autogene, as another infectious disease ...
Researchers at the Johns Hopkins Kimmel Cancer Center validated an artificial intelligence (AI)-powered blood test that accurately detected liver cancer in people from two geographically and ...
CellOrigin, a biotechnology company focused on next-generation in vivo and in vitro cell therapy technologies, has announced two major progresses in both research and strategic partnership. At the ...
Earlier this year, the Lacks estate settled a lawsuit regarding a company’s profiting off of HeLa cells. The case serves as a ...
Pluvicto now approved across PSMA+ metastatic prostate cancer, nearly doubling eligible patient population; PSMAddition ...
Johnson & Johnson also gains an exclusive option to acquire Sail Biosciences for $2.58 billion. The deal puts J&J in the mix ...
Former UW Carbone Cancer Center director will guide clinical strategy as Cofactor expands patient access to predictive RNA diagnostics for immunothera ...
Researchers at The University of Texas MD Anderson Cancer Center have discovered a strategy to overcome PARP inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results